Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Hong Kong Stock ExchangeTotal Valuation
Jilin Province Huinan Changlong Bio-pharmacy Company Limited carries a market capitalization of 1.30B, placing it among publicly traded companies globally. Its enterprise value stands at 259.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.30B |
| Enterprise Value | 259.99M |
Share Statistics
Jilin Province Huinan Changlong Bio-pharmacy Company Limited currently has 560.25M shares outstanding.
| Shares Outstanding | 560.25M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Jilin Province Huinan Changlong Bio-pharmacy Company Limited trades at a trailing price-to-earnings ratio of 5.64. The price-to-sales ratio is 0.99, and the price-to-book ratio stands at 0.60.
| PE Ratio | 5.64 |
| PS Ratio | 0.99 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Jilin Province Huinan Changlong Bio-pharmacy Company Limited trades at an EV/EBITDA multiple of 1.63 and an EV/FCF ratio of 675.51. The EV/Sales ratio of 0.31 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1.63 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.31 |
| EV / EBITDA | 1.63 |
| EV / EBIT | 1.63 |
| EV / FCF | 675.51 |
Financial Position
Jilin Province Huinan Changlong Bio-pharmacy Company Limited maintains a current ratio of 1.66, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.43, indicating elevated leverage, while an interest coverage ratio of 309.28 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.66 |
| Quick Ratio | 0.90 |
| Debt / Equity | 5.43 |
| Debt / EBITDA | 0.50 |
| Interest Coverage | 309.28 |
Financial Efficiency
Jilin Province Huinan Changlong Bio-pharmacy Company Limited posts a return on equity of 10.14 and a return on invested capital of 7.69.
| Return on Equity (ROE) | 10.14 |
| Return on Assets (ROA) | 6.32 |
| Return on Invested Capital (ROIC) | 7.69 |
| Return on Capital Employed (ROCE) | 9.89 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.18 |
Taxes
Over the trailing twelve months, Jilin Province Huinan Changlong Bio-pharmacy Company Limited has paid 50.11M in income taxes, reflecting an effective tax rate of 25.27.
| Income Tax | 50.11M |
| Effective Tax Rate | 25.27 |
Stock Price Statistics
Jilin Province Huinan Changlong Bio-pharmacy Company Limited's stock has gained approximately 7.90698% over the past 52 weeks. The 50-day moving average sits at 2.45, while the 200-day moving average is 2.24.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.90698% |
| 50-Day Moving Average | 2.45 |
| 200-Day Moving Average | 2.24 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Jilin Province Huinan Changlong Bio-pharmacy Company Limited generated 841.55M in revenue and converted that into 148.21M in net income, yielding earnings per share of 0.26. EBITDA reached 159.28M, while operating income came in at 159.28M.
| Revenue | 841.55M |
| Gross Profit | 584.05M |
| Operating Income | 159.28M |
| Pretax Income | 198.31M |
| Net Income | 148.21M |
| EBITDA | 159.28M |
| EBIT | 159.28M |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
Jilin Province Huinan Changlong Bio-pharmacy Company Limited holds 655.59M in cash and equivalents against 80.40M in total debt, resulting in a net debt position of -271.74M. Total book value stands at 1.40B, with working capital of 475.85M providing operational flexibility.
| Cash & Cash Equivalents | 655.59M |
| Total Debt | 80.40M |
| Net Debt | -271.74M |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 2.49 |
| Working Capital | 475.85M |
Margins
Jilin Province Huinan Changlong Bio-pharmacy Company Limited operates with a gross margin of 69.40, reflecting its pricing power and cost economics. The operating margin of 18.93 and net profit margin of 17.61 provide insight into operational efficiency.
| Gross Margin | 69.40 |
| Operating Margin | 18.93 |
| Pretax Margin | 23.57 |
| Profit Margin | 17.61 |
| EBITDA Margin | 18.93 |
Scores
Jilin Province Huinan Changlong Bio-pharmacy Company Limited posts an Altman Z-Score of 2.24, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.24 |